Cargando…
Safety and Efficacy of Adjunctive Therapy With Artesunate in the Treatment of Severe Malaria: A Systematic Review and Meta-Analysis
Objective: The purpose of this meta-analysis of longitudinal studies is to determine the safety and efficacy of artesunate combined with other forms of adjunctive therapies for severe malaria. Methods: Following the PRISMA guidelines, we searched multiple databases with the search terms “artesunate”...
Autores principales: | Zou, Yuanyuan, Tuo, Fei, Zhang, Zhiqi, Guo, Jiawen, Yuan, Yueming, Zhang, Hongying, Xu, Zhiyong, Pan, Ziyi, Tang, Yexiao, Deng, Changsheng, Julie, Nadia, Wu, Wanting, Guo, Wenfeng, Li, Changqing, Huang, Xinan, Xu, Qin, Song, Jianping, Wang, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748123/ https://www.ncbi.nlm.nih.gov/pubmed/33343367 http://dx.doi.org/10.3389/fphar.2020.596697 |
Ejemplares similares
-
Efficacy and Safety of Artemisinin-Piperaquine for the Treatment of Uncomplicated Malaria: A Systematic Review
por: Wang, Qi, et al.
Publicado: (2020) -
The Effect of Artemisinin-Based Drugs vs Non-artemisinin-based Drugs on Gametophyte Carrying in the Body After the Treatment of Uncomplicated Falciparum Malaria: A Systematic Review and Meta-analysis
por: Zou, Yuanyuan, et al.
Publicado: (2022) -
Surveillance of the Efficacy of Artemisinin–Piperaquine in the Treatment of Uncomplicated Plasmodium falciparum Malaria Among Children Under 5 Years of Age in Est-Mono District, Togo, in 2017
por: Wang, Qi, et al.
Publicado: (2020) -
Network pharmacology-based predictions of active components and pharmacological mechanisms of Artemisia annua L. for the treatment of the novel Corona virus disease 2019 (COVID-19)
por: Tang, Yexiao, et al.
Publicado: (2022) -
Safety and efficacy of artemisinin-piperaquine for treatment of COVID-19: an open-label, non-randomised and controlled trial
por: Li, Guoming, et al.
Publicado: (2021)